- 专利标题: Paclitaxel enhancer compounds
-
申请号: US11244324申请日: 2005-10-05
-
公开(公告)号: US07345094B2公开(公告)日: 2008-03-18
- 发明人: Keizo Koya , Lijun Sun , Shoujun Chen , Noriaki Tatsuta , Yaming Wu , Mitsunori Ono
- 申请人: Keizo Koya , Lijun Sun , Shoujun Chen , Noriaki Tatsuta , Yaming Wu , Mitsunori Ono
- 申请人地址: US MA Lexington
- 专利权人: Synta Pharmaceuticals Corp.
- 当前专利权人: Synta Pharmaceuticals Corp.
- 当前专利权人地址: US MA Lexington
- 代理机构: Hamilton, Brook, Smith & Reynolds, P.C.
- 主分类号: A61K31/16
- IPC分类号: A61K31/16 ; C07C327/00 ; C07C233/00
摘要:
Disclosed is a compound represented by the Structural Formula (I): Y is a covalent bond, a phenylene group or a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both >C=Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or —C(R7R8)—. R1 and R2 are independently an aryl group or a substituted aryl group, R3 and R4 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. R5-R6 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. R7 and R8 are each independently —H, an aliphatic or substituted aliphatic group, or R7 is —H and R8 is a substituted or unsubstituted aryl group, or, R7 and R8, taken together, are a C2-C6 substituted or unsubstituted alkylene group. Z is ═O or ═S. Also disclosed are pharmaceutical compositions comprising the compound of the present invention and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a subject with cancer by administering to the subject a compound of Structural Formula (I) in combination with Paclitaxel or an analog of Paclitaxel.
公开/授权文献
- US20060122183A1 Taxol enhancer compounds 公开/授权日:2006-06-08